Inicio/Acciones/BMY

BMY

USD

Bristol-Myers Squibb Company Common Stock

$45.590+0.100 (0.220%)

Precio en Tiempo Real

Healthcare

Drug Manufacturers - General

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$45.490

Máximo

$46.590

Mínimo

$45.380

Volumen

9.01M

Fundamentos de la Empresa

Capitalización de Mercado

92.8B

Industria

Drug Manufacturers - General

País

United States

Estadísticas de Negociación

Volumen Promedio

14.51M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $42.52Actual $45.590Máximo $63.33

Noticias Relacionadas

3 nov 2025 · 09:55

BusinessWire

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

Bristol-Myers Squibb Company (NYSE:BMY) ("Bristol Myers Squibb" or the "Offeror"), announced the commencement of tender offers ("Offers") to purchase for cash certain of its outstanding notes (collectively, the "Notes")

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

30 oct 2025 · 11:41

Reuters

Bristol Myers beats quarterly revenue estimates on strong Opdivo sales

Bristol Myers Squibb beat Wall Street estimates for third-quarter revenue on Thursday, as strong growth of its cancer immunotherapy and blood thinner Eliquis helped the drugmaker overcome a hit from generic competition for several older drugs.